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The growing interest in the biomedical application of nanomedicine is largely
attributable to its unique and appealing features in targeted delivery, controlled
release
and improved bioavailability. Currently, nanomedicines can be broadly divided
into the
following categories: lipid nanoparticles, polymeric nanoparticles, inorganic
nanoparticles and virus nanoparticles. Among them, lipid based nanomedicine
such as
liposomes, solid lipid nanoparticles, lipid micelles and extracellular vesicles, which
are
characterized by high biological compatibility and substantial drug-loading
capability,
are considered the most successful drug delivery systems known to date.
To achieve sufficient quality control and highly-efficient drug delivery, properties
such as particle size and size distribution, particle concentration, drug content,
fraction
of drug encapsulation and surface ligand density must be precisely characterized.
Because of the complexity and the large intrinsic heterogeneity of lipid
nanomedicines
in particle size and composition, rapid and rigorous characterization at the
singleparticle
level is of fundamental importance to reveal the individual difference that
would be otherwise averaged out in ensemble measurements. However, it is very
challenging to achieve multiparameter and quantitative analysis of lipid
nanomedicines














Whereas cryo-TEM can provide valuable size and morphology information with
maximum structure preservation of lipid nanomedicines, its routine application is
prevented due to the poor accessibility, low throughout and the time-consuming
sample
preparation. Other commercialized single-particle techniques also fall short in
fulfilling
the requirement for nanomedicine characterization owing to the limited sensitivity
and
resolution or the lack of multiparameter analysis ability. Thus, it is of vital
importance
to develop a rapid, sensitive and high-throughput quantitative characterization
method
at the single particle level for the analysis and development of lipid
nanomedicines.
Flow cytometry is a single particle detection technique for rapid, multiparameter
and quantitative analysis and sorting of individual cells or cell-size particles in
suspension. Due to the limitation of sensitivity, conventional flow cytometer can
only
be applied to the analysis of particles with large size or strong fluorescence.
However,
it is extremely difficult for conventional flow cytometer to achieve multiparameter
analysis of drug-loading lipid nanoparticles smaller than 200 nm. Integrating light
scattering with strategies for single-molecule fluorescence detection in a sheathed
flow,
our laboratory have developed high sensitivity flow cytometry (HSFCM) that
enables














level of single fluorescent molecules for the first time. The light-scattering based
size
detection limits for single nanoparticles are 24 nm and 7 nm in diameter for silica
and
gold nanoparticles, respectively. And the fluorescence detection limit is three
fluorescent molecules of alexa fluor 555. By offering high-resolution analysis of
single
nanoparticles in liquid suspensions at a throughput of up to 10 000 particles per
minute,
HSFCM can reveal the size distribution in minutes which would take hours for
cryo-
TEM to accomplish. Moreover, through fluorescence detection, the multiple
biochemical properties of single particles and their correlation can be
quantitatively
characterized.
Taking advantage of the superior resolution, sensitivity, detection speed and the
capability of multi-parameter analysis of HSFCM, we develop a rapid
characterization
method for lipid nanomedicines in this dissertation, which allows the absolute
quantification of particle size, drug content, fraction of drug encapsulation, particle
concentration and the surface ligand density of liposomal nanomedicines at the
singleparticle
level. This novel method aims to meet the characterization challenge of lipid
nanomedicine and to promote its development. This dissertation consists of the
following sections:
In chapter one, the research background of nanomedicine and the single particle













Chapter two introduces the side scattering based size measurement of lipid
nanomedicines by HSFCM. Using silica nanoparticles with various size as the
standards, we successfully characterized the size distribution of doxorubicin-
loaded liposomes. Furthermore, we discuss the influence of the particle refractive
index on the
light-scattering based detection of liposomal nanoparticles. We propose that a
calibration of scattering intensity should be applied via Rayleigh scattering theory
when
sizing nanoparticles with refractive index different from the standards. At last, to
achieve a perfect match of particle refractive index, we developed a strategy by
using
well prepared and size characterized doxorubicin-loaded liposomes as standards
for the
measurement of commercial nanomedicine products.
Chapter three presents the side scattering and fluorescence dual-parameter
detection of lipid nanomedicines. By means of that, drug encapsulation fraction,
serum
stability and particle concentration of doxorubicin encapsulated liposomes could
be
characterized. Furthermore, by using fluorescent silica nanoparticles with various
molecules of equivalent soluble fluorochrome (MESF) or the well-prepared
doxorubicin-loaded liposomes as standards respectively, we revealed the drug
content
distribution of doxorubicin-loaded liposomes. Applications of this analysis method
for
the multiparameter characterization of commercial doxorubicin-loaded liposomes














Chapter four describes the preparation and multiparameter characterization of
targeted liposomes. Firstly, using folate coupled liposomes as a model, we
develop a
quantitative characterization method for the surface ligand density and studied its
biological impact on the cell binding ability of liposomes. Besides, the influence of
preparation methods and PEG length on the ligand density distribution and
heterogeneity is also elucidated. Finally, the method is applied to the transferrin or
antibody coupled liposomes, and a novel evaluation method for the proportion of
available ligand number in total protein content is established.
In chapter five, the work of this thesis is summarized and the future prospect in
single lipid nanoparticle analysis is discussed.
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